Nucleonics' Series B Round

Nucleonics raised a round of funding on June 16, 2004.

Nucleonics is developing a method of RNA interference to silence disease-causing genes. Initially, the company is applying its technology to develop expressed interfering RNA (eiRNA) therapies for the…

Articles about Nucleonics' Series B Round: